Keynote 1: Craig Blackstone, MD, PhD - National Institutes of Neurological Disorders and Stroke
Dr. Craig Blackstone serves as Senior Investigator and Section Chief of the Neurogenetics Branch of National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH). Dr. Blackstone is also the Director of the NIH MD/PhD Partnership Training Program and Vice President of the American Neurological Association. Dr. Blackstone received his B.S. and M.S. degrees from the University of Chicago and his M.D. and Ph.D. degrees from Johns Hopkins University. He then completed his neurology residency at the Harvard-Longwood Neurology Program, followed by a concurrent clinical movement disorders fellowship at Massachusetts General Hospital and post-doctoral fellowship at Harvard Medical School. As a physician-scientist, Dr. Blackstone has established an impressive career studying the cellular mechanisms underlying neuromuscular and movement disorders. We are honored to have Dr. Blackstone present a keynote speech at SEMSS this year.
Keynote 2: Margaret Baron, MD, PhD - Icahn School of Medicine at Mount Sinai
Dr. Baron is the Fishberg Professor of Medicine in Medicine, Hematology, and Medical Oncology, Oncological Sciences, and Cell, Developmental and Regenerative Biology. She also serves as the Senior Associate Dean for Education and Director of the MD/PhD Program and Director of the Program in Hematology and Blood Disorders at Mount Sinai. After graduating from Harvard summa cum laude, Dr. Baron received her MD from Harvard Medical School and her PhD from M.I.T. through their Program in Health Sciences and Technology. She went on to Internal Medicine residency at Massachusetts General Hospital and a post-doctoral fellowship at Harvard University. Dr. Baron was an assistant and then associate professsor at Harvard before moving to Mount Sinai in 1997. Dr. Baron is an internationally renowned developmental biologist and her research has made important contributions to the understanding of hematopoietic development. Dr. Baron's work as a physician-scientist investigator exemplifies interdisciplinary and translational science, and her dedication to mentorship and teaching have helped her become a leader in her field. We are very grateful that Dr. Baron will share her career insights with us this year.
Keynote 3: Lucienne M. Ide, MD, PhD - Healthcare Innovator
Dr. Ide is a healthcare innovator and CEO of Rimidi, Inc., and brings her diverse experiences in medicine, science, venture capital, and technology to transforming the delivery of healthcare for chronic diseases. Rimidi’s cloud-based diabetes management platform provides a comprehensive solution for healthcare systems that connects healthcare providers with their patients. Rimidi enables providers to receive a clear snapshot of each patient's diabetes numbers and unique needs by merging patient and clinical data and provides them with decision support tools to make personalized treatment decisions. Dr. Ide founded Rimidi with the purpose of improving the health of the chronically ill and the healthcare system as a whole. “Our digital health technology helps health systems achieve the Quadruple Aim of improved outcomes, better patient experience, lower overall cost of care for patients, and improved clinician satisfaction,” says Dr. Ide.
Prior to starting Rimidi in 2012, Dr. Ide worked as a physicist at the National Security Agency, Raytheon Systems Corporation and Monarch Capital Partners, a venture capital firm. She holds a joint M.D./Ph.D. degree from Emory University, and completed her medical training at the University of Pennsylvania Medical College’s Magee Womens’ Hospital in Pittsburgh. A speaker on women in technology and digital health innovation, Dr. Ide has been a guest speaker at many health IT conferences and has been published on Forbes.com. A member of the App Association, an industry trade organization advocating healthcare reform, she has spent time on Capitol Hill meeting with legislative officials about digital health. She also is a board member of the Georgia Community Leadership Board of the American Diabetes Association and a founder of I Can Be The Change, a not-for-profit focused on educating youth on obesity-related health issues. She serves as a Trustee of Middlebury College in Vermont. Rimidi has been named a Top 5 Company to Watch by the Georgia Pharmacists Association and a Top 10 Innovative Company in Georgia by the Technology Association of Georgia. Rimidi also is an ATDC Select Company. Additionally, the company received a “Platinum” ranking by BAnalytics as a socially conscious company.
Rimidi has been featured in Reuters, The Economist, The Huffington Post, and MobiHealth News, as well as local media, including the Atlanta Journal-Constitution, and the Atlanta Business Chronicle. Dr. Ide lives in Atlanta with her husband and their four sons. We very much look forward to learning more about Dr. Ide's unique and innovative career path at SEMSS this year.